| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | LNTH Lantheus Holdings, Inc. | Leno Sam R | Director | Sell | 7,012 | $80.75 | $566,200.48 | -5.8% | +7.5% | -27.0% | |
| Mar 27, 2023 | EOLS Evolus, Inc. | Moatazedi David68 | See Remarks | Sell | 6,110 | $8.47 | $51,751.70 | -1.0% | -12.2% | +64.7% | |
| Mar 27, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $217.49 | $3,479,905.92 | -29.1% | +1.3% | +13.7% | |
| Mar 24, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 20,000 | $1.44 | $28,752.00 | - | - | - | |
| Mar 24, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $335.82 | $67,164,554.71 | - | +36.2% | +129.3% | |
| Mar 24, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 46,000 | $0.04 | $2,061.00 | - | - | - | |
| Mar 24, 2023 | MRK Merck & Co., Inc. | Romanelli Joseph57 | President, Human Health Int?l | Sell | 35 | $104.65 | $3,662.75 | -0.2% | +9.2% | +21.4% | |
| Mar 23, 2023 | TSNDF Terrascend Corp. | Ghanem Ziad | President And COO | Buy | 8,000 | $1.44 | $11,520.00 | +17.8% | - | - | |
| Mar 23, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 21,600 | $1.45 | $31,240.08 | - | - | - | |
| Mar 23, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $215.23 | $3,443,755.57 | -30.4% | +3.3% | +10.1% | |
| Mar 22, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 56,000 | $0.05 | $2,634.00 | - | - | - | |
| Mar 21, 2023 | TSNDF Terrascend Corp. | Ghanem Ziad | President And COO | Buy | 15,000 | $1.41 | $21,150.00 | +50.0% | - | - | |
| Mar 21, 2023 | AMLX Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 63,448 | $31.91 | $2,024,494.48 | -0.4% | -19.3% | -90.2% | |
| Mar 21, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $223.91 | $3,582,484.68 | -22.5% | +0.5% | +6.5% | |
| Mar 21, 2023 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO And President | Sell | 64,500 | $18.97 | $1,223,313.42 | -36.7% | +2.6% | -85.6% | |
| Mar 20, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 9,333 | $9.54 | $89,055.49 | -1.9% | -13.6% | +61.9% | |
| Mar 20, 2023 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 5,002,100 | $0.01 | $25,088.30 | +2.0% | - | - | |
| Mar 17, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 13,745 | $9.79 | $134,563.55 | -7.6% | -9.7% | +50.2% | |
| Mar 17, 2023 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 526 | $1.78 | $937.49 | -0.7% | -11.6% | +33.5% | |
| Mar 17, 2023 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 6,170 | $9.79 | $60,404.30 | -28.7% | -9.7% | +50.2% | |
| Mar 17, 2023 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 15,720 | $9.83 | $154,449.00 | -6.9% | -9.7% | +50.2% | |
| Mar 17, 2023 | ESPR Esperion Therapeutics, Inc. | Foody Joanne M.73 | Chief Medical Officer | Sell | 3,808 | $1.78 | $6,785.48 | -2.9% | -11.6% | +33.5% | |
| Mar 17, 2023 | PFE Pfizer Inc | Pfizer Inc | 10% Owner | Buy | 1,811,594 | $2.76 | $4,999,999.44 | +43.8% | -0.9% | -30.3% | |
| Mar 17, 2023 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.60 | President And CEO | Sell | 6,999 | $1.78 | $12,479.22 | -2.3% | -11.6% | +33.5% | |
| Mar 17, 2023 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $217.74 | $3,483,775.56 | -23.5% | +4.5% | +7.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.